Published in Neuropsychologia on January 01, 1994
Basal forebrain amnesia: does the nucleus accumbens contribute to human memory? J Neurol Neurosurg Psychiatry (1999) 1.48
Lateral and anterior thalamic lesions impair independent memory systems. Learn Mem (2006) 1.03
Unraveling the contributions of the diencephalon to recognition memory: a review. Learn Mem (2011) 1.02
The medial dorsal thalamic nucleus and the medial prefrontal cortex of the rat function together to support associative recognition and recency but not item recognition. Learn Mem (2012) 0.98
Neural circuitry for rat recognition memory. Behav Brain Res (2014) 0.93
Memory without context: amnesia with confabulations after infarction of the right capsular genu. J Neurol Neurosurg Psychiatry (1996) 0.90
Moderate injury in motor-sensory cortex causes behavioral deficits accompanied by electrophysiological changes in mice adulthood. PLoS One (2017) 0.75
Computer control of anticoagulant dose for therapeutic management. BMJ (1989) 3.87
Relative sparing of item recognition memory in a patient with adult-onset damage limited to the hippocampus. Hippocampus (2002) 3.19
Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial. Arch Intern Med (2000) 2.36
Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. Structure (1999) 2.09
Electrostatic charge interactions in ordered powder mixes. J Pharm Pharmacol (1982) 1.97
A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone. Lancet (1973) 1.85
Serial study of C-reactive protein during infection in leukaemia. J Clin Pathol (1981) 1.79
Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet (2000) 1.58
What the patient wants to know about Crohn's disease. J Clin Gastroenterol (1983) 1.48
When is now? Perception of simultaneity. Proc Biol Sci (2001) 1.46
Transverse myelitis after measles, mumps, and rubella vaccine. BMJ (1995) 1.39
Verocytotoxin-1 induces apoptosis in vero cells. J Infect (1995) 1.27
Time-dependent deformation of some direct compression excipients. J Pharm Pharmacol (1978) 1.23
Naming impairments following recovery from herpes simplex encephalitis: category-specific? Q J Exp Psychol A (1992) 1.22
A prevalence survey of multiple sclerosis in Sussex. J Neurol Neurosurg Psychiatry (1995) 1.19
Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome. J Clin Pathol (1985) 1.19
Visual paired comparison performance is impaired in a patient with selective hippocampal lesions and relatively intact item recognition. Neuropsychologia (2004) 1.13
The use of a biological adhesive to achieve sutureless epikeratophakia. Eye (Lond) (1989) 1.07
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology. J Clin Pathol (1993) 1.06
Haemophilia and the kidney: assessment after 11-year follow-up. Br Med J (Clin Res Ed) (1982) 1.06
Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome. Arch Dis Child (1984) 1.05
The Hopscotch Jak kinase requires the Raf pathway to promote blood cell activation and differentiation in Drosophila. Mol Genet Genomics (2002) 1.02
Protein domains connect cell cycle stimulation directly to initiation of DNA replication. Proc Natl Acad Sci U S A (1994) 1.02
Experimental epikeratophakia with biological adhesive. Arch Ophthalmol (1988) 1.01
Memory for single items, word pairs, and temporal order of different kinds in a patient with selective hippocampal lesions. Cogn Neuropsychol (2001) 1.00
The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner. Proc Natl Acad Sci U S A (1996) 1.00
Is the international normalised ratio (INR) reliable? A trial of comparative measurements in hospital laboratory and primary care settings. J Clin Pathol (1999) 0.99
Alpha 1-adrenergic and cholinergic agonists use separate signal transduction pathways in lacrimal gland. Am J Physiol (1992) 0.99
Malignant fibrous histiocytoma of the ethmoid sinus. J Laryngol Otol (1983) 0.98
Interparticle forces in binary and ternary ordered powder mixes. J Pharm Pharmacol (1982) 0.98
Analysis of heat-shock protein expression in myeloid leukaemia cells by flow cytometry. Br J Haematol (1995) 0.97
Relations between compaction data for some crystalline pharmaceutical materials. Pharm Acta Helv (1975) 0.94
Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa. Q J Med (1974) 0.93
Errorless learning of novel associations in amnesia. Neuropsychologia (1997) 0.93
Vasoactive intestinal polypeptide stimulation of protein secretion from rat lacrimal gland acini. Am J Physiol (1984) 0.93
A laboratory model of toxin-induced hemolytic uremic syndrome. Kidney Int (1999) 0.92
Cytopathic effect of verotoxin on endothelial cells. Lancet (1987) 0.91
Change in background context disrupts performance on visual paired comparison following hippocampal damage. Neuropsychologia (2009) 0.91
Temporal order memory in patients with Korsakoff's syndrome and medial temporal amnesia. Neuropsychologia (2002) 0.91
Limitations of the Heckel relation for predicting powder compaction mechanisms. J Pharm Pharmacol (1978) 0.90
Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease. J Neurol Neurosurg Psychiatry (1973) 0.89
Predicting spontaneous recovery of memory. Nature (2001) 0.89
Susceptibility of AML cells to in vitro apoptosis correlates with heat shock protein 70 (hsp 70) expression. Br J Haematol (1996) 0.89
The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome. Pediatr Nephrol (1990) 0.87
Wernicke-Korsakoff syndrome of nonalcoholic origin. Brain Cogn (1991) 0.85
Alpha 1-adrenergic agonist-stimulated protein secretion in rat exorbital lacrimal gland acini. Exp Eye Res (1994) 0.83
Accelerated long-term forgetting in temporal lobe but not idiopathic generalised epilepsy. Neuropsychologia (2011) 0.83
Using anticoagulation or aspirin to prevent stroke. Patients should be assessed for risk factors before deciding on prophylaxis. BMJ (2000) 0.83
Bilateral temporal lobe pathology with sparing of medial temporal lobe structures: lesion profile and pattern of memory disorder. Neuropsychologia (1994) 0.83
Psychophysical assessment of a patient with Tolosa-Hunt syndrome. J Neurol Neurosurg Psychiatry (1983) 0.83
Regional cerebral blood-flow in transient ischaemic attacks. Lancet (1970) 0.83
Differential sensitivity to context in diencephalic and temporal lobe amnesia. Cortex (1990) 0.82
Lineage determination during haemopoiesis and classification of myelodysplastic disorders. Br J Haematol (1986) 0.82
Role of cyclic AMP and Ca2+ in potentiation of rat lacrimal gland protein secretion. Invest Ophthalmol Vis Sci (1988) 0.81
Myxoid meningioma: histochemistry and electron microscopy. Acta Neuropathol (1985) 0.81
Mixing of particulate solids to ensure homogeneity of dosage forms: the need for a critical approach to pharmaceutical process development. Boll Chim Farm (1977) 0.81
Pathogenesis of haemolytic uraemic syndrome. Lancet (1988) 0.80
Renal failure and the histopathological features of myeloma kidney reversed by intensive chemotherapy and peritoneal dialysis. Br Med J (Clin Res Ed) (1987) 0.80
Memory loss following radiotherapy for nasal pharyngeal carcinoma--an unusual presentation of amnesia. Br J Clin Psychol (1991) 0.79
Immunologic therapy for hemolytic-uremic syndrome. J Pediatr (1989) 0.79
Contextual cueing effects in the remote memory of alcoholic Korsakoff patients and normal subjects. Q J Exp Psychol A (1990) 0.78
The use of the xenon clearance method in subarachnoid haemorrhage. Eur Neurol (1972) 0.78
Human memory: the hippocampus is the key. Curr Biol (1996) 0.77
Role of calcium in cholinergic stimulation of lacrimal gland protein secretion. Curr Eye Res (1985) 0.77
The comparative analysis of isotope clearance curves in normal and ischemic brain. Stroke (1971) 0.77
Proceedings: Evaluation of a small scale fluidized bed granulation unit. J Pharm Pharmacol (1975) 0.77
Carnitine and weakness in haemodialysis patients. Nephrol Dial Transplant (1989) 0.76
Primary intracerebral mesenchymal chondrosarcoma with rhabdomyosarcomatous differentiation: case report and literature review. Br J Neurosurg (2001) 0.76
A comparison of international normalised ratio (INR) measurement in hospital and general practice settings: evidence for lack of standardisation. J Clin Pathol (2000) 0.76
A comparison of stochastic, compartmental and flow initial analysis of rCBF data in a group of normal and ischaemic patients. Eur Neurol (1972) 0.76
Ethanol-induced chronic myopathy in the young rat: a light and electron microscopic study in type I or type II fibre-rich skeletal muscles. Alcohol Alcohol (1992) 0.76
Plasminogen activator inhibitor activity in diarrhoea-associated haemolytic uraemic syndrome. QJM (1994) 0.75
Congenital teratoma of the submandibular gland. J Pediatr Surg (1982) 0.75
Morphological heterogeneity in childhood B cell acute lymphoblastic leukaemia. J Clin Pathol (1984) 0.75
Computer control of anticoagulant dose. BMJ (1990) 0.75
Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry (1974) 0.75
Managing the increased workload in anticoagulant clinics. Computerised decision support is valuable. BMJ (1996) 0.75
A new (K1518E) candidate mutation detected by universal heteroduplex generator analysis in a patient with type 2A (phenotype IIA) von Willebrand disease. Thromb Haemost (1998) 0.75
Classification of haemolytic uraemic syndrome. J Clin Pathol (1986) 0.75
A comprehensive anticoagulant management support system (AMSS) Clin Lab Haematol (1989) 0.75
Impaired temporal context memory on anterograde but not retrograde tests in the absence of frontal pathology. Cortex (1993) 0.75
Fluctuating dementia and rhinorrhoea. Postgrad Med J (1995) 0.75
Re-learning in Alzheimer's disease. Int J Geriatr Psychiatry (1999) 0.75
A stiff man with malabsorption. J R Soc Med (1988) 0.75
Primary central nervous malignant melanoma in the bathing trunk naevus syndrome. Postgrad Med J (1989) 0.75
Use of different histomorphometric parameters in the routine assessment of human skeletal muscle biopsies. Anal Cell Pathol (1996) 0.75
The use of a compression modulus to describe compaction behaviour. J Pharm Pharmacol (1970) 0.75
Progenitor cells and classification of myelodysplastic and myeloproliferative disorders. Lancet (1985) 0.75
Serological reactions using low ionic strength saline (LISS) in patients with rheumatoid arthritis. Med Lab Sci (1983) 0.75
Use of interferon-2 alpha in the treatment of cryoglobulinaemic leg ulcers. Clin Lab Haematol (1995) 0.75
Relation between mixing time and segregation of ordered mixes. J Pharm Pharmacol (1981) 0.75
Malignant optic nerve gliomas in adults. J Clin Neuroophthalmol (1985) 0.75
Laboratory management of the haemolytic uraemic syndrome. Med Lab Sci (1986) 0.75
The effect of rate of loading on the strength of tablets. J Pharm Pharmacol (1970) 0.75
Improved tables for the evaluation of sphere size distributions including the effect of section thickness. J Microsc (1980) 0.75
Segregation of vibrated powder mixes containing different concentrations of fine potassium chloride and tablet excipients. J Pharm Pharmacol (1983) 0.75
Effect of vibration time, frequency and acceleration on drug content uniformity. J Pharm Pharmacol (1982) 0.75
Interacting effects of dibutylchloromethyltin chloride, 2,3-dimercaptopropanol, and other reagents on mitochondrial respiration and K+ flux. J Bioenerg Biomembr (1983) 0.75